Suven Life Sciences Q2 Results
- BSE: 530239
- NSE: SUVEN
- ISIN: INE495B01038
- Sector: Biotechnology & Drugs
BSE
283.15
-5.45 (-1.89%)
-5.45 (-1.89%)Volume40.97 K
Updated: Fri 9 Oct, 2026 | 15:29:47
NSE
282.75-6.15 (-2.13%)
-6.15 (-2.13%)Volume5.83 L
Updated: Fri 9 Oct, 2026 | 15:50:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Suven Life Sciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 82.01 | 138.22 | 51.91% | 56.24 | 45.82% |
| Depreciation/ Amortization | 1.32 | 2.16 | -3.77% | 1.46 | -9.50% |
| Operating Income | -81.09 | -,134.66 | 55.59% | -53.66 | 51.10% |
| Net Income | -77.31 | -,127.61 | 50.07% | -49.64 | 55.73% |
| Net Income Before Taxes | -77.31 | -,127.61 | 50.07% | -49.64 | 55.73% |
| Other Operating Expenses Total | 4.29 | 4.96 | -16.67% | 1.99 | 115.35% |
| Total Revenue | 0.92 | 3.57 | -50.76% | 2.57 | -64.27% |
| Selling/ General/ Admin Expenses Total | 6.08 | 7.28 | 1.69% | 5.20 | 16.78% |
| Diluted Normalized EPS | -3.48 | -4.84 | 47.31% | -2.27 | 53.30% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.